Search research articles
Contact Us
Filters
Showing results (111-120 of 184) with videos related to
Page
of 19
Sort By:
Oral Oncology
|
December 16, 2019
Validation and characterisation of prognostically significant PD-L1<sup>+</sup> immune cells in HPV+ oropharyngeal squamous cell carcinoma
Richard J Young, Mathias Bressel, Sandro Porceddu, et al.
Prenatal Diagnosis
|
January 30, 2020
The utility of exome sequencing for fetal pleural effusions
Angie C Jelin, Nara Sobreira, Elizabeth Wohler, et al.
Health Data Science
|
May 6, 2026
Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry Data
Jianrong Zhang, Maarten J IJzerman, Damien McCarthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2015
Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer
Toni-Maree Rogers, Prudence A Russell, Gavin Wright, et al.
Clinical Lung Cancer
|
May 5, 2024
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT)
Andrew Fantoni, Lydia Warburton, Benjamin Solomon, et al.
Clinical and Translational Radiation Oncology
|
February 20, 2020
Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma
Lachlan McDowell, Georgina Casswell, Mathias Bressel, et al.
Clinical Lung Cancer
|
June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Jose Luis Leal, Marliese Alexander, Malinda Itchins, et al.
Molecular Cancer Therapeutics
|
October 9, 2021
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations
Brion W Murray, Evan Rogers, Dayong Zhai, et al.
Pathology
|
November 1, 2019
Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer
Nick Pavlakis, Caroline Cooper, Thomas John, et al.
ESMO Open
|
December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
Grace Chazan, Fanny Franchini, Marliese Alexander, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 184) with videos related to
Sort By:
Page
of 19
Oral Oncology
|
December 16, 2019
Validation and characterisation of prognostically significant PD-L1<sup>+</sup> immune cells in HPV+ oropharyngeal squamous cell carcinoma
Richard J Young, Mathias Bressel, Sandro Porceddu, et al.
Prenatal Diagnosis
|
January 30, 2020
The utility of exome sequencing for fetal pleural effusions
Angie C Jelin, Nara Sobreira, Elizabeth Wohler, et al.
Health Data Science
|
May 6, 2026
Diagnostic Delays in Thoracic Cancer Care: A Data-Linkage, Cohort Study between Primary Care, Hospital, and Registry Data
Jianrong Zhang, Maarten J IJzerman, Damien McCarthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2015
Comparison of methods in the detection of ALK and ROS1 rearrangements in lung cancer
Toni-Maree Rogers, Prudence A Russell, Gavin Wright, et al.
Clinical Lung Cancer
|
May 5, 2024
Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT)
Andrew Fantoni, Lydia Warburton, Benjamin Solomon, et al.
Clinical and Translational Radiation Oncology
|
February 20, 2020
Patient-reported quality of life and toxicity in unilateral and bilateral radiotherapy for early-stage human papillomavirus associated tonsillar carcinoma
Lachlan McDowell, Georgina Casswell, Mathias Bressel, et al.
Clinical Lung Cancer
|
June 15, 2021
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
Jose Luis Leal, Marliese Alexander, Malinda Itchins, et al.
Molecular Cancer Therapeutics
|
October 9, 2021
Molecular Characteristics of Repotrectinib That Enable Potent Inhibition of TRK Fusion Proteins and Resistant Mutations
Brion W Murray, Evan Rogers, Dayong Zhai, et al.
Pathology
|
November 1, 2019
Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer
Nick Pavlakis, Caroline Cooper, Thomas John, et al.
ESMO Open
|
December 2, 2020
Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians
Grace Chazan, Fanny Franchini, Marliese Alexander, et al.
Page
of 19